U.S. Deputy Secretary for Health and Human Services, Andrea Palm, and Sweden's Minister for Health Care, Acko Ankarberg Johansson, signing the agreement. Credit: Joel Apelthun/Government Offices of SwedenThe United States and Sweden signed an agreement to step up collaborations in science and technology by focusing on cancer research.
In a major breakthrough in cellular therapy, FDA has approved the first tumor-infiltrating lymphocyte therapy for patients with unresectable or metastatic melanoma who have received prior treatment, including with checkpoint inhibitors.
Feb. 16, 2024, is a landmark date in the history of immuno-oncology.
As a student at MIT in the 1970s, Roderic Pettigrew was writing his PhD thesis on how a controlled nuclear reaction in the brain, boron neutron activation therapy, could be used to treat glioblastoma multiforme.